www.dendron.nihr .ac.uk

Improving Patient Participation in Research

Networking Event20th March 2013

Follow the event on #Dendron

Introductions

Professor Ian McKeithDirector DeNDRoN

Professor of Old Age PsychiatryNewcastle University

Background

• In 2011 the Ministerial Advisory Group for Dementia Research recommended that we:

– Improve the consistency of support for dementia research– Extend public engagement in research– Embed the delivery of research across the full care pathway

• In response DeNDRoN established the INTERACT Project and put these objectives central to delivery.

Aims for the event

• During 2012 DeNDRoN Local Research Networks have been testing different ways to put research with care, improving patient participation and recruitment to studies.

• The aims for todays event are to:

– share the work undertaken across DeNDRoN Local Research Networks– network and discuss the different ways of delivery– launch the Patients in Research Infokit to act as a platform for showcasing work across the NHS

and research network to inspire openness, sharing and new ways of working

AgendaWelcome and introduction - Professor Ian McKeith, Consultant Old Age Psychiatrist, Director DeNDRoN, University of Newcastle 09:30 – 09:35

Embedding research in the NHS - Dr Jonathan Sheffield, Chief Executive, NIHR CRN 09:35 – 10.00

Creating a research culture - Heidi Neild, Assistant Director of R&D, HSJ Research Culture Award Winner 10.00 – 10:30

Refreshment break 10:30 – 11:00

Group 1 Culture Zone / Group 2 Integration Zone / Group 3 Partnership Zone 11:00 – 12.15

Lunch - Patients in research cyber café / Poster presentations 12:15 – 13.00

Group 1 Integration Zone / Group 2 Partnership Zone / Group 3 Culture Zone 13:00 – 14:15

Refreshment break 14:15 – 14:30

Group 1 Partnership Zone / Group 2 Culture Zone / Group 3 Integration Zone 14:30 – 15:45

Sharing ways to deliver – Patients in Research Infokit - Dr Chris Ball, Consultant Old Psychiatrist, Chair INTERACT 15.45 – 16.00

Embedding research in the NHS

Dr Jonathan SheffieldChief Executive NIHR Clinical Research Network

Heidi NeildAssistant Director of R&D

Southampton University Hospital NHS Foundation Trust

Creating a research culture

The UHS Perspective

Clinical Research at UHS

UHS Progress2006

• ~£8m R&D Levy • ~500 R&D studies

– ? patients

• Research low priority• ?commercial research income

• Joint R&D Office• Welcome Trust Clinical

Research Facility• Central and South Coast

Cancer Research Network

2012• ~£20m R&D income• ~800 R&D studies

– ~250 recruiting (NIHR)– >15,000 patients (NIHR)

• Research is Core Business• 100% increase in commercial

research income• R&D Business Unit

– Joint R&D Office– NIHR and Non-NIHR

Research Centres and Units– Cancer network– CLRN

NHS engagement

Strategies

1. Trust Board leadership

2. R&D structure

3. Financial restructuring

4. Workforce development

5. Performance management

6. Information Management and Technology

7. Communications

8. Rewards and incentives

Pat

ient

s an

d pu

blic

Patients and public

Patients and public

1. Trust Board Leadership

“To be a world class centre of clinical academic achievement, where staff work together to ensure

patients receive the highest standards of care and the best people want to come to learn, work and research.”

CEO January 2006

1. Trust Board Leadership• Trust Vision• Key influencers identified• Regular meetings with key influencers• Understand agenda’s• Board presentations• Strategic objectives• Board reports• Key performance indicators• National Awards

• Constant reminders!

• Key people– Chairman– Chief Executive– Director of Finance– Medical Director – Chief Operating Officer– Non-executive Director

2. Providing a structure for R&D

Chief Operating Officer

Division A

Surgery

Cancer Care

Critical Care

Theatres

Division B

Emergency Medicine

Specialist Medicine

Ophthalmology

Radiology

Pathology

Division C

Women and newborn

Child health

Support Services e.g. pharmacy

Non-clinical support

Division D

Cardiovascular and Thoracic

Neurosciences

Trauma and Orthopaedics

Divisional and Care Group Management Teams• Divisional Clinical Director• Divisional Director of Operations• Divisional Head of Nursing/Midwifery/Professions• Care Group Clinical Lead• Care Group Manager

Divisional R&D LeadsDivisional Research

FacilitatorsCare Group R&D Leads

The Southampton Clinical Research Partnership

UoS Faculties

UoS Research Centres

UHS Clinical Service

National – e.g. NIHR, MRC, NOCRI, UKCMRI, OSCHR, TRP, NHS, Academia

Local – Southampton Partnership

International – e.g. Non-UK Govt, Academia, Global Pharma/Biotech/Technology

SCBRNIHR BRC

NIHR Respiratory BRUNIHR ECMC

NIHR/WT CRFNIHR CTU

Cardiovascular UnitMusculoskeletal Unit

Wessex Investigational Science Hub

UHSNIHR

Topics & Specialties

Pre-clinical discovery

Experimental Medicine

Later phase research

R&D Business Unit

3. Financial restructuring• Increased transparency• Financial re-structure• Ring-fenced R&D Business Unit• All R&D income• Ring-fenced budgets for NIHR Units and Nursing & AHP pool• Devolved to divisions with targets• Income distribution policies• Robust business cases• Robust budget setting and monitoring• Internal recovery systems

Key people• Chief Executive• Director of Finance• Medical Director

Key appointments• R&D Finance Team

4. Workforce development

• CLRN and R&D Investment calls– Consultant PAs– Research support staff

• Robust business planning– Research units e.g. Critical care

• Clinical Academic Development Fund

• Flexible research nurse and AHP pool– Clinical trials assistants

• Joint appointments/secondments– Nurses and AHPs– Clinical Academics– Clinical Consultants

• Training

• Key people– Chief Executive– Medical Director– Director of Nursing– Director of HR– UoS Faculty of Medicine Dean– UoS Faculty of Health Sciences Dean

• Key appointments– Divisional R&D Leads– Senior Research Nurse Managers– Professor of Nursing

5. Performance management

• Strategic objectives• Key performance indicators• Divisional Performance reviews• Streamlining e.g. R&D approval

• Key people– Chief Executive– Service improvement lead– Research Governance and QA Manager– Divisional R&D Leads

• Key appointments– Information Manager

• Key challenges– Lack of fit for purpose information systems– Changing goal posts– Information overload

6. Information Management and Technology

• Local Portfolio Management System

Key People• Chief Executive• Director of IM&T

Key appointments• R&D Information Manager

7. Communications

• Branding• Web presence• Market research• Marketing materials • Press releases• Patient screens• Open days• Develop relationships

– Patient and public partners– Funding bodies– Commercial partners

• Patient pull

Key People• Chief Executive• Director of Communications

Key appointments• R&D Communications Manager

8. Rewards and Incentives• Commercial Research Income Distribution Policy

• New investment– Business plans

Awards• PharmaTimes Clinical Research Site• HSJ NIHR Progressive Research Culture• Hospital Heroes

– Best clinical impact– Research individual or team of the year– Contract commercial research highest performer

• Key people– Chief Executive– Director of Finance– Principal Investigators– Medical Director– UoS Faculty Deans– Head of Wider Healthcare Teams Education– Senior Research Nurse Managers– Divisional R&D Leads

Dr Chris BallINTERACT Chair, Consultant Old Age PsychiatristSouth London & Maudsley NHS Foundation Trust

Sharing ways to deliver

Sharing ways to deliver

• Introducing the opportunity to participate in research should be a core part of any care pathway – systematically improving patients access.

• What we learn from today is that there are many ways this can be achieved – universal themes, irrespective of the field.

– changing culture– partnering with others– integrating research into care pathways

Sharing ways to deliver

• We hope that the stories and information gathered today have been useful, and have inspired you to try different approaches.

• To properly share the work undertaken in these projects we created:

www.patientsinresearch.org

• The Patients in Research Infokit a platform for any organisation to share ideas and best practice.

• To showcase work from across the NHS and research community to improve patient participation in research and recruitment to studies.

• Putting research with care. www.patientsinresearch.org

Patients In Research Infokit

• Launching V1 today – it features:

– Complete information on all 19 of the DeNDRoN Projects– Video and audio clips of the people who delivered– Case studies, top tips and guidance– Tools and materials to support spread and adoption– General advise, guidance tools to support delivery

• From the NHS Institute - NHS Change Model

• Grouped into three themes – Integration, Partnership & Culture

Partnership

Culture

Integration

Next Steps

• What do we want now?

– Take what you have learned today, improve on it, and act on it.– Be proactive and creative – Putting more patients in touch with research, and research with care– Make your contribution to the Patients in Research Infokit

DeNDRoN non-commercial studies currently in set-up represent an estimated £35M investment in dementias and neurodegenerative diseases research. This demonstrates how DeNDRoN is supporting researchers, and ensuring the government’s commitment to double research funding is supported.

Over the past two years DeNDRoN has provided pre-application support for 39 studies for approximately £36m around half these have already received funding.

To ensure funding and studies remain focused on the needs of patients, DeNDRoN has also established task forces to improve studies in Parkinson’s Disease, Motor Neuron Diseases, Huntington’s Disease and for all forms of Dementia.

Delivering for Dementia & Neurodegenerative Disease

DeNDRoN has supported over 50,000 patients to become involved in clinical research over the past four years – more than doubling the annual number of participants.

DeNDRoN is involved with 247 trusts, and leads the way in performance in the commercial sector with 80% of studies in 2011-2012 delivered on time and target.

In quarter 3 (Oct-Dec) of 2012-13 DeNDRoN delivered on 100% of non-commercial studies to target and time.

DeNDRoN has supported over 400 studies in the past four years, and is currently supporting delivery of over 125 studies across England. This number will significantly increase over the next 3 years, reflecting the government priority on dementia.

Delivering for Dementia & Neurodegenerative Disease

Thank you